Welcome to our dedicated page for American Oncology Network news (Ticker: AONC), a resource for investors and traders seeking the latest updates and insights on American Oncology Network stock.
American Oncology Network (AONC) operates a community-based oncology network that partners with independent oncology and hematology practices. Recurring company news covers practice additions, clinic openings, physician recruitment, and regional expansion across community cancer-care markets.
Company updates also address support services for partner practices, including in-house pharmacy, laboratory support, clinical trial access, back-office operations, and revenue-diversifying programs. News involving the network’s practices includes outpatient oncology services, infusion therapy, blood-disorder care, CAR T-cell therapy, bispecifics, radiopharmaceuticals, patient advocacy, and participation in community oncology policy and industry forums.
American Oncology Network (NASDAQ:AONC) announced that multiple research studies co-authored by its physicians and leaders were selected for presentation at the ASCO 2026 Annual Meeting, held May 29–June 2 in Chicago.
Topics span clinical trials, AI-driven registries, pharmacovigilance, health disparities, and large language model evaluation, underscoring AON’s role in community oncology research.
AON reports that its practices currently offer access to more than 150 clinical trials, bringing innovative treatment options to local communities.
Zangmeister Cancer Center, a partner of American Oncology Network (NASDAQ:AONC), has become an affiliate of Ohio State’s OSUCCC – James through The James Cancer Network. The collaboration expands community-based cancer care across central Ohio, including access to more than 500 clinical trials and advanced therapies.
Patients gain local access to subspecialized oncology and hematology expertise, CAR T-cell therapy, stem cell transplant evaluation, tumor-infiltrating lymphocyte (TIL) therapy and proton therapy at OSUCCC – James, while maintaining strong ties to community care teams.
Elkhart Hematology and Oncology (formerly Elkhart Clinic’s hematology and oncology practice) joined American Oncology Network (AONC) on May 5, 2026, expanding patient access to clinical trials and community-based cancer care. The practice will continue onsite infusion, centralized lab/pathology, specialty pharmacy, care coordination and financial counseling.
Dr. Ahsanul Haque and Charisse Prall, FNP-BC will continue to lead clinical services and are accepting new patients.
MidAmerica Cancer Care (AONC) announced that Dr. Syed Karim, a board-certified medical oncologist and hematologist, has joined the physician team and is accepting new patients at the Belton location.
Dr. Karim brings more than 10 years of clinical experience in the Kansas City area and completed fellowships at George Washington University and Georgetown University Hospital. For more information visit maccsp.com and AONcology.com.
The Center for Cancer and Blood Disorders (AONC) received authorization to administer FDA-approved CAR T-cell therapy and has begun treating its first community oncology patient in the Maryland-area clinic as of April 23, 2026. The program offers outpatient CAR T and bispecific therapy access across Maryland, Washington, D.C., and Northern Virginia, led by Dr. Ralph Boccia and a multidisciplinary CCBD team. CCBD previously ran four outpatient CAR T trials and three outpatient bispecific trials, and coordinates closely with local hospitals to manage monitoring, safety, and follow-up care.
American Oncology Network (NYSE:AONC) will speak at the 2026 Community Oncology Alliance Annual Conference, April 28-29 in Orlando. AON leaders will deliver 11 sessions on topics including CAR T, radiopharmaceuticals, clinical trials, payer data, patient advocacy and careers in community oncology. AON will exhibit at booth 207.
Messino Cancer Centers (AONC) opened a new clinic in South Asheville on March 18, 2026, expanding to its sixth location at 1815 Hendersonville Road, Suite 103.
The clinic is open Tuesdays–Thursdays 8 AM–5 PM, includes an on-site lab, private exam rooms and an infusion suite with eight chairs; breast cancer care is available from Board-certified physicians Dr. Rachel Raab and Dr. Emily Miller.
Oncology Consultants (AONC) announced on March 5, 2026 that it has joined American Oncology Network (AON), expanding clinical trial access and operational resources while preserving its physician-led independence. The practice operates 18 locations across South Texas with 16 medical oncologists, 3 radiation oncologists and 23 advanced practitioners.
The partnership aims to enhance patient access to advanced therapies, reduce administrative burden, maintain local care delivery and support long-term sustainability for community-based oncology services.
American Oncology Network (AONC) partner practice Fort Wayne Medical Oncology and Hematology expanded services at Cameron Health in Angola, Indiana, effective March 4, 2026, to increase local access to comprehensive cancer care.
Renovations added an expanded lobby, dedicated registration, five new exam rooms, a private physician office and 12 infusion bays, plus support areas; the facility also recently installed a new linear accelerator. FWMOH will increase days of on-site medical oncology, hematology, infusion therapy and palliative/supportive services to serve rising cancer rates in Steuben County.
RKV Medical Center (AONC) in Muskogee, Oklahoma, joined American Oncology Network on Feb 4, 2026 as AON’s first partner practice in the state.
The partnership aims to expand access to clinical trials, advanced therapies, onsite infusion and radiation services, specialty pharmacy, centralized labs, and continued community-based care under Dr. Ravikumar Vasireddy.